Biolase CEO Flynn steps down | Personnel Moves – April 13, 2018
Biolase (NSDQ:BIOL) said this week its CEO Harold Flynn has resigned from the company to pursue other interests, and that current CFO John Beaver will step in to act as interim CEO. The transition will be made immediately, the Irvine, Calif.-based company said. “I would like to thank Harold for the leadership and commitment he has demonstrated over the last three years.  We are grateful for his contributions to product quality and for his steadfast dedication to Biolase.  We thank him for his continued support and wish him all the best in this new phase of his professional career. We are pleased to hav...
Source: Mass Device - April 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Biolase Conventus Orthopaedics Endotronix Inc. Frequency Therapeutics General Electric Henry Schein Inc. mckeonproducts nsfhealthsciencescertification Omnicell Inc. PerkinElmer Inc. personnel-moves Source Type: news

Response and Development of Immune-Related Adverse Events in an 83-Year-Old Man With Metastatic Urothelial Cancer
An 83-year-old man was diagnosed with multiple low-grade transitional cell carcinomas over a 6-year period. A surveillance cystoscopy in year 7 showed high-grade noninvasive papillary urothelial carcinoma in the bladder trigone. A CT urogram showed a soft-tissue mass with diffuse enhancement in the lower pole of the left kidney, concerning for malignancy. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Daniel P. Petrylak, MD Karishma K. Mehra, MD Tags: Bladder Cancer Genitourinary Cancers Oncology Journal Source Type: news

Jury Awards $22M in Asbestos-Contaminated Paint Case
A California jury recently awarded $22 million to the estate of a man exposed to asbestos-containing talc that was used in paint manufacturing, expanding the liability of those supplying the toxic ingredient. Plaintiff Richard Booker, who worked as a paint maker throughout his career, died of mesothelioma in 2016. The lawsuit claimed Booker was exposed to asbestos while working for Dexter Midland Chemical Co. and Walter N. Boysen Paint Co. The lucrative award includes $4.6 million in punitive damages, along with the initial judgement of $17.57 million for malice on the part of Vanderbilt Minerals and Imerys Talc America In...
Source: Asbestos and Mesothelioma News - January 2, 2018 Category: Environmental Health Authors: Daniel King Tags: Alameda County asbestos exposure asbestos-contaminated talc Cashmere Bouquet Colgate-Palmolive Dexter Midland Chemical Imerys Talc America mesothelioma lawsuit Richard Booker Vanderbilt Minerals Walter N. Boysen Paint Source Type: news

Immune Checkpoint Inhibitors Effective for Advanced Urothelial, Renal Cancers Immune Checkpoint Inhibitors Effective for Advanced Urothelial, Renal Cancers
In patients with advanced urothelial cell and renal cell cancers, immune checkpoint inhibitors (ICIs) are more effective and safer than conventional second-line treatment, a new systematic review from The Netherlands reports.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 18, 2017 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Shape of prostate and compartments within may serve as cancer indicators
Preliminary computerized imaging reveals the shape of the prostate and a compartment within the gland -- called the transitional zone -- consistently differ in men with prostate cancer than those without the disease, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2017 Category: Science Source Type: news

Shape of prostate and compartments within may serve as cancer indicators
(Case Western Reserve University) Preliminary computerized imaging reveals the shape of the prostate and a compartment within the gland -- called the transitional zone -- consistently differ in men with prostate cancer than those without the disease, according to new research led by Case Western Reserve University. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2017 Category: Cancer & Oncology Source Type: news

Unequal Housework Could Be Damaging Women's Health
We've long known that the way couples divide housework can have a serious impact on a woman's career. For example, in her 2013 book Lean In, Facebook COO Sheryl Sandberg advises women that unless their partners pitch in with at least 50 percent of the housework and childcare, they may not advance as much as they would like to in their workplace. Research backs this up: One reason there are so few women in leadership positions could be because women continue to do the majority of housework and childcare even in households in which both partners work full-time, according to a McKinsey study.  Now, a new study ...
Source: Healthy Living - The Huffington Post - June 22, 2016 Category: Consumer Health News Source Type: news

You Are Not Your Illness: Do Not Become Your Aches and Pains
In addition to following good medical advice, there are ways to help your mindbody maximize wellbeing and minimize the negative effects of illnesses and medication side effects. I propose there are three main components that determine the difference between empowerment and helplessness consciousness during adversity: Especially important when dealing with the challenges of an illness. Identification: To identify with a negative condition makes you the condition. This does not mean denial of an illness. Instead, it's recognition that you are more than what is not working well in your mindbody. Attribution: The cause th...
Source: Healthy Living - The Huffington Post - June 16, 2016 Category: Consumer Health News Source Type: news

Cognitive Tech is the R&D Game-Changer
2016 may be the year where Artificial Intelligence (AI) leaps firmly from science fiction into the present. Recently, Google’s DeepMind AlphaGo program scored a landmark victory for AI, beating the world champion Lee Se-dol at Go, a game so fiendishly complex that the best players rest on attuned intuition to make decisions. Since Alan Turing famously defined the tests for AI in terms of capacities that mimic human intelligence, it was inevitable that progress would be showcased by human-machine duels. But while landmark moments make for great public spectacle, like IBM Deep Blue beating grandmaster Kasparov at chess...
Source: EyeForPharma - June 16, 2016 Category: Pharmaceuticals Authors: Thomas Disley Source Type: news

Cognitive Tech is the R & D Game-Changer
2016 may be the year where Artificial Intelligence (AI) leaps firmly from science fiction into the present. Recently, Google ’s DeepMind AlphaGo program scored a landmark victory for AI, beating the world champion Lee Se-dol at Go, a game so fiendishly complex that the best players rest on attuned intuition to make decisions. Since Alan Turing famously defined the tests for AI in terms of capacities that mimic human intelligence, it was inevitable that progress would be showcased by human-machine duels. But while landmark moments make for great public spectacle, like IBM Deep Blue beating grandmaster Kasparov at ch...
Source: EyeForPharma - June 16, 2016 Category: Pharmaceuticals Authors: Thomas Disley Source Type: news

Cancer Drugs Fund consultation
NHS England -The aim of the new Cancer Drugs Fund (CDF) is to help patients receive new treatments with genuine promise, while real world evidence is collected for up to two years on how well they work in practice. This will then help determine whether the treatment should be accepted for routine use in the NHS in the future. The original CDF was established in 2011 to fund cancer drugs in England that are not currently approved by NICE and will run until April 2016. The CDF has helped more than 72,000 cancer patients in England access drugs not routinely funded, but it is now widely acknowledged that a new system is neede...
Source: The Kings Fund - Health Management Specialist Collection - November 19, 2015 Category: Health Management Authors: The King's Fund Information & Knowledge Service Tags: Consultations Source Type: news

Consultant in endocrinology – Hull Royal Infirmary, Hull, UK
Applications are invited for the post of Consultant in Endocrinology to join a team of eight Consultants in the Department of Diabetes, Endocrinology and Metabolism at Hull Royal Infirmary. This post is for pure clinical endocrinology. The successful applicant will be encouraged to further develop a subspecialty area of interest in Endocrinology within the unit. General Medical on-call and ward duties will be shared with colleagues currently in post. Subspecialty services include: pituitary disease, thyroid disease and thyroid eye disease, reproductive medicine, adrenal and gonadal disease. There are joint clinics with neu...
Source: Society for Endocrinology - July 23, 2014 Category: Endocrinology Source Type: news

Research could lead to new cancer assay, aid both dogs and humans
(Oregon State University) Veterinary researchers have identified a unique group of proteins that indicate the presence of transitional cell carcinoma -- the most common cause of bladder cancer -- and may lead to a new assay which could better diagnose this disease in both dogs and humans. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 5, 2014 Category: Biology Source Type: news

Vietnam Pharmaceutical Market Value to Hit $8 Billion by 2020 says a...
ReportsnReports.com adds “Country Focus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam” to its store. Order a copy of this report @...(PRWeb June 02, 2014)Read the full story at http://www.prweb.com/releases/urothelial-cell-cancer/market-2014-analysis/prweb11905015.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2014 Category: Pharmaceuticals Source Type: news

Annals of Internal Medicine tip sheet for May 27, 2014
(American College of Physicians) The May 27, 2014, issue of Annals of Internal Medicine covers articles titled: 'Task Force: Screen high-risk individuals for hepatitis B'; 'Postnatal immunoprophylaxis effective for preventing maternal transmission of hepatitis B'; 'Some transitional care interventions more effective than others for reducing mortality, readmissions after heart failure'; and 'Analysis shows cancer center ads heavy on emotion, light on information.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 26, 2014 Category: Global & Universal Source Type: news

Kidney cancer survival improves
The report examines trends in survival of kidney cancer in England over 20 years (1990 to 2010) and found that people diagnosed with the main type of kidney cancer, renal cell carcinoma, have seen an overall improvement in survival. However, for around 10% of patients diagnosed with rarer types of kidney cancer such as transitional cell carcinoma (TCC), there has been no significant change. This could be because TCC is less likely to be detected early via medical imaging, but also because of less advances in developing successful treatments. (Source: NHS Networks)
Source: NHS Networks - April 17, 2014 Category: UK Health Authors: Maria Axford Source Type: news

What scientific idea is ready for retirement?
Each year a forum for the world's most brilliant minds asks one question. This year's drew responses from such names as Richard Dawkins, Ian McEwan and Alan Alda. Here, edge.org founder John Brockman explains how the question came into being and we pick some of the best responsesEdge.org was launched in 1996 as the online version of "the Reality Club", an informal gathering of intellectuals who met from 1981 to 1996 in Chinese restaurants, artist lofts, investment banking firms, ballrooms, museums, living rooms and elsewhere. Though the venue is now in cyberspace, the spirit of the Reality Club lives on in the li...
Source: Guardian Unlimited Science - January 12, 2014 Category: Science Authors: The Observer Tags: Astronomy Biology Mathematics Technology Physics Features Internet Animal behaviour The Observer Science Source Type: news

Just Released: "Transitional Cell Carcinoma"
Global Markets Direct's, 'Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.07/16/2013 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 16, 2013 Category: Cancer & Oncology Source Type: news

Current Perspectives in Bladder Cancer ManagementCurrent Perspectives in Bladder Cancer Management
This overview focuses on current best-evidence in the diagnosis and management of transitional cell carcinoma, which comprises over 90% of bladder cancers. International Journal of Clinical Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

New Clues about Origins of Ovarian Cancer
Researchers have discovered a possible site of origin of epithelial ovarian cancer.According to research published in March 6 in the journal Nature, researchers have discovered a possible origin of epithelial ovarian cancer.  The origin of ovarian cancer is unclear, making the development of a method of early detection very difficult.  Scientists know that some epithelial cancers occur in transitional zones between two types of epithelium (layers of tissue that line the body and organs and form glands), while others originate in epithelial tissue stem cells. All organs have the capacity for regeneration, which is...
Source: OCRF News - April 8, 2013 Category: Cancer & Oncology Source Type: news

NICE issues final guidance on vinflunine for advanced or metastatic transitional cell carcinoma of the urothelial tract (TA 272)
Source: NICE Area: Evidence> Drug Specific Reviews NICE has issued final guidance which does not support the use of vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed after treatment with platinum-based chemotherapy (TA 272).   The Committee noted that vinflunine does not provide enough benefit to patients to justify its high cost, and did not qualify for special consideration.   See links below for further details. (Source: NeLM - Drug Specific Reviews)
Source: NeLM - Drug Specific Reviews - January 23, 2013 Category: Drugs & Pharmacology Source Type: news